ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.061,49
-0,20%
S&P 500
5.659,34
0,50%
US Dollar vs BRL
5,4331
-0,28%
Bitcoin
64.771,41
-0,11%
Brent Oil
83,245
-1,30%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Allos Therapeutics, Inc. (MM) (ALTH)

  7. Allos Therapeutics, Inc. (MM) (ALTH) Notícias

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALTH
DataHoraFonteTítuloCódigoCompanhia
19/04/200916:00Business WireAllos Therapeutics’ Pralatrexate Demonstrates Anticancer Activity in Multiple Cancer Cell LinesNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
15/04/200909:00Business WireAllos Therapeutics to Present at the American Association for Cancer Research Annual Meeting 2009NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/04/200917:05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/04/200917:00Business WireAllos Therapeutics Announces Closing of Common Stock OfferingNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/04/200917:10Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
31/03/200910:00Business WireAllos Therapeutics Announces Pricing of Common Stock OfferingNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/03/200918:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/03/200909:00Business WireAllos Therapeutics to Present at the 4th Annual Citi Biotech DayNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/03/200909:00Business WireAllos Therapeutics Submits New Drug Application for Pralatrexate for Patients with Relapsed or Refractory Peripheral T-cell L...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/03/200918:30Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/03/200909:00Business WireAllos Therapeutics Appoints David M. Stout to Its Board of DirectorsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/03/200909:00Business WireAllos Therapeutics’ Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Bladder Cancer by the Eu...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/03/200918:00Business WireAllos Therapeutics Reports 2008 ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/02/200918:00Business WireAllos Therapeutics to Report 2008 Results on March 3, 2009NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/02/200918:24Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/02/200919:49Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
09/12/200819:00Business WireAllos Therapeutics to Present at the RBC Capital Markets 2008 Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/12/200814:03Business WireAllos Therapeutics Announces Top Line Results from Pivotal Phase 2 PROPEL Trial of Pralatrexate in Patients with Relapsed or ...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/12/200815:30Business WireTwo Pralatrexate Studies Presented at the 50th Annual Meeting of the American Society of HematologyNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/12/200811:00Business WireAllos Therapeutics to Host Analyst and Investor Briefing on Monday, December 8, 2008NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
01/12/200819:00Business WireU.S FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Follicular LymphomaNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/11/200819:00Business WireU.S. FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Diffuse Large B-Cell LymphomaNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/11/200820:09Edgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/11/200812:17Business WireFour Pralatrexate (PDX) Studies to Be Presented at the 50th Annual Meeting of the American Society of HematologyNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/11/200820:09Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/11/200819:00Business WireAllos Therapeutics Reports 2008 Third Quarter ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/11/200811:00Business WireAllos Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/10/200818:00Business WireFour Pralatrexate (PDX) Studies Accepted for Presentation at the 50th Annual Meeting of the American Society of HematologyNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
29/10/200810:00Business WireAllos Therapeutics to Report Third Quarter 2008 Results on November 5, 2008NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
01/10/200809:00Business WireAllos Therapeutics to Present at the JMP Healthcare Focus ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALTH

Seu Histórico Recente

BOV
HAGA3
HAGA ON
BOV
IBOV
Índice Bovespa
BOV
TELB4
TELEBRAS PN
BOV
AZEV4
AZEVEDO PN
BOV
GFSA3
GAFISA ON
BOV
AMER3
Americanas ON
BOV
NGRD3
Neogrid Participacoes ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
COGN3
COGNA ON
BOV
VVEO3
CM Hospitalar ON
BOV
JFEN3
JOAO FORTES ON
BOV
HBOR3
HELBOR ON
BOV
GOLL4
GOL PN
BOV
AGXY3
Agrogalaxy Participacoes ON
BOV
LUPA3
LUPATECH ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados